Single-use Bioprocessing Market

Single-use Bioprocessing Market Size (2022 to 2027)

The global single-use bioprocessing market is estimated to be worth USD 8.79 billion by 2027 and USD 3.92 billion in 2022, growing at a CAGR of 17.5% from 2022 to 2027.

Single-use Bioprocessing Market Share Insights:

• Based on the product, the media bags and containers segment dominated the market and held the largest share of the market in 2021.
• Based on end-user, the filtration segment led the market, accounting for the leading share in the global single-use bioprocessing market in 2021.
• North America was the most dominating region in the worldwide market in 2021 and accounted for 33.4% of the global market share in 2021.
• The European market is expected to value USD 2.46 billion by 2027.
• The Asia-Pacific region is anticipated to grow at a CAGR of 17.8% from 2022 to 2027.

Single-use bioprocessing is majorly utilized in the manufacturing of biopharmaceuticals. The technique is used throughout the biopharmaceutical production process, from buffer and media preparation to biologics shipping. Single-use bioprocessing techniques are carried out through different products. Some leading products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, and single-use mixers. These items lower the expenditure associated with the complex bioproduction procedures, such as cleaning, sterilization, and care of the big bioreactors.

MARKET DRIVERS:

Y-O-Y growth in demand for biopharmaceuticals and increasing R&D activities by pharmaceutical companies are expected to accelerate the global single-use bioprocessing market growth.

According to BioPharm International, around 85% of the pre-commercial biomanufacturing includes single-use bioprocessing infrastructure. With the rising demand for pharmaceutical products worldwide, a wide range of advanced technologies comprises automation, big data, and machine learning. In addition, the rising importance of reproduced single-use products, the establishment of ongoing biomanufacturing, and healthcare industry enhancements are other factors fuelling the global single-use bioprocessing market.

In addition, the growing popularity of disposables in biopharmaceutical manufacturing, the rising incidence of chronic diseases leading to the need for biological treatment, affordable disposable products and instruments, and the developing life science research infrastructure drive the global single-use growth bioprocessing systems market. Moreover, advancements in the technology of bioprocessing systems also fuelled the global single-use bioprocessing systems market. Therefore, growing numbers of joint ventures, acquisitions, and quick launches of new products are the significant trends in this global single-use bioprocessing systems market.

MARKET RESTRAINTS:

However, extractability problems with disposing of plastic bags and possible environmental harm are the factors restricting the growth of the single-use bioprocessing market. Moreover, the waste disposal of single-use processes is also a significant challenge faced by the market.

Impact of COVID-19 on the single-use bioprocessing market:

The COVID-19 pandemic scenario has nearly affected all industries worldwide. Single-use bioprocessing technologies command over the pre-commercial space. Most biopharmaceutical companies are quickly advancing vaccines in response to the pandemic crisis. There has been an increase in the bio/pharmaceutical companies' changes by reacting to the present COVID-19 pandemic. Bioprocessing and concerning supplies and support activities escalate. This comprises a quick increase over the crisis, infectious diseases, and relevant research, development, and manufacturing by companies and governments.

REPORT COVERAGE:

This research report has segmented and sub-segmented the global single-use bioprocessing market into the following categories.

Single-use Bioprocessing Market – By Product:

• Media Bags and Containers
• Filtration assemblies
• Single-use Bioreactors
• Disposable Mixers
• Others

Based on the product, the media bags and containers segment held the largest share of the single-use bioprocessing market in the recent past. The domination of the segment is estimated to continue during the forecast period owing to the growing adoption of media bags and containers in transportation and storage.

Single-use Bioprocessing Market – By Application:

• Filtration
• Storage
• Cell Culture
• Mixing and Purification

Based on the application, the filtration segment leads the market due to the growing popularity of single-use tangential flow filters, depth filters, and chromatography columns in the process development. Further, by End User, the market is classified into Research and Development Institutes and Biopharmaceutical manufacturers.

Single-use Bioprocessing Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the North American single-use bioprocessing market is predicted to lead the global market, followed by Europe during the forecast period. The growing adoption of biopharmaceutical manufacturing services and rising investments in R&D are propelling the regional market. The U.S. led the North American market in 2021, and the lead is expected to continue throughout the forecast period. The increased expenditure on healthcare and biologics spurs U.S. market growth. Furthermore, the continuous product launches and growing popularity of disposables are expected to favor the U.S. market. The Canadian market is expected to hold a substantial share of the North American market during the forecast period owing to the low production costs, growing awareness, and increasing incidence of chronic diseases.

The European single-use bioprocessing market accounted for a substantial share of the global market in 2021. Factors such as increasing R&D activities, growing disposable biopharmaceuticals, and immense manufacturing capabilities expand the market growth. The U.K. single-use bioprocessing market is presently leading the EU market and is forecasted to continue to play a leading role during the forecast period. On the other hand, the German market is predicted to have a tremendous growth rate due to a surge in biopharmaceutical and biotech companies, intensifying system sales. According to Statista data, the number of committed biotech companies in Germany was 593 in 2015 and has risen to 679 in 2018.

However, the single-use bioprocessing market in APAC will grow at the highest CAGR because of ample investment opportunities, especially in China, India, Australia, and New Zealand. Growing government initiatives and the efforts of key market participants to better the healthcare infrastructure is favoring the market. The Chinese market is well-known for exporting biopharmaceutical activities such as chemical drugs. In July 2019, Sartorius opened a tech support center for biotech processing in Zhangjiang, Shanghai, China. The Indian single-use bioprocessing market has had a reasonable growth rate throughout the forecast period. The rising patient count, novel diseases, and accentuating lifestyle changes are supporting the Indian market.

The single-use bioprocessing market in Latin America is predicted to have a substantial growth rate during the forecast period. The local manufacturers' focus on expanding their product portfolio, and launching new advanced technology products, are driving the Latin American market. As a result, Brazil is expected to lead the Latin American market.

The single-use bioprocessing market in MEA is projected to witness a sluggish growth rate during the forecast period. Growing demand for cost-effective bioprocessing systems is expected to drive the market.

KEY MARKET PARTICIPANTS:

Some of the prominent companies leading single-use bioprocessing market profiled in this report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.